Literature DB >> 19867681

CONCERNING AGGLUTININS FOR TREPONEMA PALLIDUM.

J A Kolmer1.   

Abstract

1. There is no demonstrable amount of agglutinin for Treponema pallidum (Noguchi) in normal human and normal rabbit serum in dilutions as low as 1:20. 2. Agglutinins for Treponema pallidum are readily produced in young rabbits by the administration of pure cultures of living spirochetes. 3. There is no appreciable amount of agglutinin for Treponema pallidum culture used in the sera of secondary and tertiary syphilis or in the cerebrospinal fluid of tertiary syphilis in dilutions of 1:20 to 1:640.

Entities:  

Year:  1913        PMID： 19867681      PMCID： PMC2125124          DOI： 10.1084/jem.18.1.18

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


  6 in total

1.  [Not Available].

Authors:  G B ROEMER
Journal:  Klin Wochenschr       Date:  1948-09-15

2.  ON THE PRESENCE IN SYPHILITIC SERUM OF ANTIBODIES TO SPIROCHETES, THEIR RELATION TO SO CALLED WASSERMANN REAGIN, AND THEIR SIGNIFICANCE FOR THE SERODIAGNOSIS OF SYPHILIS.

Authors:  H Eagle; R B Hogan
Journal:  J Exp Med       Date:  1940-01-31       Impact factor: 14.307

3.  STUDIES ON TREPONEMA PALLIDUM AND SYPHILIS : IV. THE DIFFERENCE IN BEHAVIOR IN IMMUNE SERUM BETWEEN CULTIVATED NON-VIRULENT TREPONEMA PALLIDUM AND VIRULENT TREPONEMATA FROM LESIONS.

Authors:  H Zinsser; J G Hopkins; M McBurney
Journal:  J Exp Med       Date:  1916-03-01       Impact factor: 14.307

4.  AGGLUTINATION OF TREPONEMA PALLIDUM IN HUMAN SYPHILIS.

Authors:  J A Kolmer; S Broadwell; T Matsunami
Journal:  J Exp Med       Date:  1916-10-01       Impact factor: 14.307

5.  Specific agglutination of Treponema pallidum by sera from rabbits and human beings with treponemal infections.

Authors:  P H HARDY; E E NELL
Journal:  J Exp Med       Date:  1955-04-01       Impact factor: 14.307

6.  Immobilization of Treponema pallidum in vitro by antibody produced in syphilitic infection.

Authors:  R A NELSON; M M MAYER
Journal:  J Exp Med       Date:  1949-04-01       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.